Quick Answer
SANGAMO THERAPEUTICS, INC reported Common Stock Shares Outstanding of 350.69 million shares for the year ending 2025.
- SANGAMO THERAPEUTICS, INC showed an increase of +64.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from SANGAMO THERAPEUTICS, INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), SANGAMO THERAPEUTICS, INC's Common Stock Shares Outstanding has grown by 672.8%.
- Historical annual values: Fiscal year 2025: 350.69 million shares | Fiscal year 2024: 212.84 million shares | Fiscal year 2023: 178.13 million shares | Fiscal year 2022: 166.79 million shares | Fiscal year 2021: 145.92 million shares | Fiscal year 2020: 142.06 million shares | Fiscal year 2019: 115.97 million shares | Fiscal year 2018: 102.19 million shares | Fiscal year 2017: 85.60 million shares | Fiscal year 2016: 70.87 million shares | Fiscal year 2015: 70.35 million shares | Fiscal year 2014: 69.06 million shares | Fiscal year 2013: 62.24 million shares | Fiscal year 2012: 53.06 million shares | Fiscal year 2011: 52.55 million shares | Fiscal year 2010: 45.38 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: